目的:探讨核转录因子(NF)-κB抑制剂二硫代氨基甲酸吡咯烷(PDTC)对小鼠急性心肌梗塞(AMI)后Wnt信号通路的影响。方法:结扎3月龄雄性C57/BL小鼠左冠状动脉建立AMI模型,随机分成AMI+PDTC组(36只,术后每日腹腔注射PDTC120mg/kg)。AMI组(36只,每日注射同上述剂量的生理盐水)。所有小鼠按心梗时间分3d、7d、14d亚组.比较应用PDTC后NF-κB信号通道相关的p65,wnt信号通路的Dishellved(dvl)—1mRNA表达.糖原合成激酶(GSK)3β总水平及磷酸化水平变化,β-连接蛋白(catenin)及缝隙通道连接蛋白(connexin)43表达。结果:与AMI组相比,AMI+PDTC组的p65,dvl~1mRNA表达显著降低(P均〈0.05),p/tGSK-3β3d,7d及14d时均显著升高(P值均为0.000);β—catenin表达3d时显著低于AMI组,7d时显著高于AMI组(P值均为0.000);connexin43表达显著降低(P=0.000)。结论:抑制NF—κB活性、信号通道后Wnt信号通路相关蛋白活性也发生变化,说明急性心肌梗塞后NF-κB信号通路与Wnt信号通路之间存在互通作用。
Objective: To study the effects of NF-κB inhibitor -PDTC on expression of protein related to Wnt signal pathway in mice post-infarction. Methods: Choose 3 months C57/BL mice to set up acute myocardial infarction animal model by ligation of left coronary artery . They were divided to AMI+PDTC group (36 cases, mice was treated with injected PDTC on dose of 120 mg/kg · d) and AMI group (36 cases, mice was treated with injected physiological saline with same volume) . They were divided into 3 subgroups according to time post-infarction: ad, 7d, 14d post infarction and detected expression of p65 related to NF-κB signal pathway by immunohistochemistry; and protein related to Wnt signal pathway: dvl-1 mRNA by RT PCR, total (t) and phosphorylation (p) level of glucogen synthesis kinase (GSK) -3β, β-catenin, connexin 43 by Western-blot in left ventricular. Results: Expression of p65 decreased in AMI+PDTC group (P〈0.05). Compared with AMI group expression of dvl-1 mRNA decreased in AMI +PDTC group (P〈0.05). While ratio of p/t- GSK-3β was higher in AMI+PDTC group on 3d, 7d and 14d postinfarction than it in AMI group (P= 0. 000 all). Expression of β-catenin was lower on 3d post-infarction, and in- creased on 7d postinfarction (P=0. 000) in AMI+PDTC group. Expression of eonnexin 43 was much lower in AMI +PDTC group compared with AMI group (P=0. 000). Conclusion: Expression of protein related to Wnt signal pathway also altered after used NF-κB inhibitor -PDTC. That means "crosstalk" existed between Wnt and NF-κB signal pathway postinfarction.